• ARCA Cy5 EGFP mRNA: A Readout Architecture

  2026-09-29

  ARCA Cy5 EGFP mRNA (5-moUTP) enables a dual-readout strategy for separating mRNA delivery, localization, and translation. This article explains how cap biology, Cy5 tracking, EGFP expression, and immune-response controls can improve interpretation of mammalian-cell delivery studies.

• From Sulfo-Cy5 Chemistry to Mucosal Vaccine Insight

  2026-09-29

  A translational framework for using Sulfo-Cy5 carboxylic acid to interrogate nanoparticle biodistribution, mucosal targeting, and immune-response mechanisms without overstating preclinical evidence.

• Cy5 Maleimide for Condensate Assays

  2026-09-28

  Cy5 maleimide enables site-specific cysteine labeling for sensitive protein and condensate assays. This guide explains how non-sulfonated Cy5 maleimide can report molecular partitioning while controlling for dye charge, solvent effects, and labeling-induced artifacts.

• JNJ-26481585 (Quisinostat) in Pituitary Tumor Research

  2026-09-28

  Use Quisinostat to investigate how broad HDAC inhibition intersects with TRIM21–ERK signaling and dopamine-agonist resistance in pituitary adenoma models. This practical workflow pairs early pathway readouts with proliferation and apoptosis assays so that changes in TRIM21 are not mistaken for proof of a specific mechanism.

• SlSLAH1 Links STOP1 to Tomato Aluminum Tolerance

  2026-09-27

  A 2026 study identifies the plasma-membrane channel SlSLAH1 as a malate transporter that contributes to aluminum tolerance in tomato. It describes a regulatory module in which SlSTOP1–SlSZP1 activates SlSLAH1, while SlSLAH2 partners with SlSLAH1 to support malate exudation from roots.

• EZ Cap Cy5 Firefly Luciferase mRNA for LNP Assays

  2026-09-26

  Separate cellular uptake from productive expression with Cy5 fluorescence and firefly luciferase in one reporter construct. A recent hepatic LNP study shows why ligand performance depends on PEG-lipid context—and how this dual-readout mRNA can help compare formulations without mistaking uptake for delivery success.

• Aprotinin and GRO-seq: Protecting Assay Interpretability

  2026-09-25

  Aprotinin, or bovine pancreatic trypsin inhibitor, is best understood not only by its protease targets but also by where it belongs in an experimental workflow. This article connects its biochemical profile to a practical question raised by GRO-seq: how can sample-processing choices preserve interpretable results without introducing untested biological effects?

• PLGA Nano-Adjuvant Boosts Mucosal Immunity in Chicks

  2026-09-25

  The study reports a PLGA-based, multi-component adjuvant designed to combine sustained antigen delivery with intestinal immune targeting in chicks vaccinated against H9N2 avian influenza. The formulation was associated with higher serum IgG and intestinal IgA responses, alongside changes in cytokines, T-cell differentiation, and intestinal structure; its proposed trafficking and signaling mechanisms merit further validation.

• Redox-Responsive Peptide Coacervates for mRNA Delivery

  2026-09-24

  Ren and colleagues developed HBpep-SS4, a single-component peptide coacervate designed to protect diverse RNA cargos and release them in reducing intracellular conditions. The reported results include high RNA encapsulation, delivery across multiple cell lines, and genome editing, while leaving important questions about in vivo performance and clinical translation open.

• ASB3 Targets MAVS to Suppress Antiviral Immunity

  2026-09-24

  The study identifies ASB3 as an E3 ubiquitin ligase that weakens antiviral innate immunity by directing K48-linked ubiquitination and proteasomal degradation of MAVS. Its cell-based and animal findings connect this mechanism to reduced type I interferon responses and greater susceptibility to influenza infection, while suggesting practical ways to investigate MAVS regulation.

• BCA Protein Quantification Kit K4102 Guide

  2026-09-23

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit (SKU K4102) measures total protein in low-concentration samples for workflows such as lysate normalization. It is intended for research use, not diagnostic or medical testing; sample compatibility should be checked for the specific buffer and matrix.

• Necrostatin-1: Linking Necroptosis and Redox Stress

  2026-09-23

  Necrostatin-1 is a selective RIP1 kinase inhibitor for dissecting necroptosis, inflammation, and tissue injury. This article presents a reference-informed strategy for pairing RIP1 inhibition with redox and ferroptosis assays without confusing mechanistically distinct death pathways.

• RPS6 as a Translational Node in PDAC Biology

  2026-09-22

  The LRRC8A–Caveolin-1 axis connects membrane organization with KRAS/EGFR signaling, ribosome biogenesis, and pancreatic cancer growth. This article explains how the Anti-RPS6 (7B10) Mouse Monoclonal Antibody can help translational researchers turn that mechanism into a disciplined, multi-assay validation strategy.

• EX 527: Mapping SIRT1 in Bone Regeneration

  2026-09-22

  EX 527 (SEN0014196) offers translational researchers a selective way to test how SIRT1 catalytic activity connects p53 acetylation, DNA damage responses, endothelial function, and osteogenic regeneration.

• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-09-21

  Turn one mRNA input into two complementary measurements: Cy5 tracks delivery and intracellular trafficking, while Firefly Luciferase reports functional translation. This practical workflow shows how to optimize mRNA delivery and transfection, distinguish uptake from expression, and troubleshoot formulation, imaging, and assay variability.

8020 records 1/535 page Next 12345 下5页 Last page